Provided by Tiger Fintech (Singapore) Pte. Ltd.

Geron

1.32
-0.0445-3.27%
Volume:5.48M
Turnover:7.47M
Market Cap:839.31M
PE:-9.94
High:1.41
Open:1.38
Low:1.31
Close:1.36
52wk High:4.84
52wk Low:1.09
Shares:638.02M
Float Shares:538.90M
Volume Ratio:0.45
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1324
EPS(LYR):-0.2702
ROE:-31.09%
ROA:-9.63%
PB:3.23
PE(LYR):-4.87

Loading ...

Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS

Business Wire
·
Mar 12

Geron CEO Scarlett to leave company

TIPRANKS
·
Mar 12

BRIEF-Geron Corporation Announces Departure Of CEO

Reuters
·
Mar 12

Geron Corporation Announces Departure of Chief Executive Officer

Business Wire
·
Mar 12

Insider Moves: Air Products, Inseego, Coterra, Geron, Green Thumb

TIPRANKS
·
Mar 08

James Ziegler Buys Handful Of Shares In Geron

Simply Wall St.
·
Mar 05

Analysts Just Shaved Their Geron Corporation (NASDAQ:GERN) Forecasts Dramatically

Simply Wall St.
·
Mar 01

Geron removed from Best List Ideas at Wedbush

TIPRANKS
·
Feb 28

Geron Corporation’s Earnings Call: Mixed Sentiments and Strategic Shifts

TIPRANKS
·
Feb 28

Stock Track | Geron Corp. Soars 6.2% as Rytelo Launch Fuels Strong Q4, but Flat Recent Trends Pose Challenge

Stock Track
·
Feb 27

Stock Track | Geron's Stock Soars 6.2% as Rytelo Gains Traction in Lower-Risk MDS Market

Stock Track
·
Feb 27

Analysts Are Bullish on Top Healthcare Stocks: United Therapeutics (UTHR), Geron (GERN)

TIPRANKS
·
Feb 27

Geron price target lowered to $4 from $9 at Barclays

TIPRANKS
·
Feb 27

Geron Is Maintained at Buy by Needham

Dow Jones
·
Feb 27

U.S. RESEARCH ROUNDUP-Abbvie, Freeport-McMoran, Goldman Sachs

Reuters
·
Feb 27

Geron Corp (GERN) Q4 2024 Earnings Call Highlights: Strong Cash Position and Rytelo's FDA ...

GuruFocus.com
·
Feb 27

Q4 2024 Geron Corp Earnings Call

Thomson Reuters StreetEvents
·
Feb 27

Why Geron Stock Is Plummeting Today

Motley Fool
·
Feb 27

Wedbush Lowers Geron's Price Target to $7 From $8, Outperform Rating Maintained

MT Newswires Live
·
Feb 27

Geron Shares Drop After Wider-Than-Expected 4Q Loss

Dow Jones
·
Feb 27